patent/IL-202429-A0

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
filingDate	2009-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2010-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IL-202429-A0
titleOfInvention	Metabolites of the janus kinase inhibiting (r)-3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
priorityDate	2007-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43569 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25126798 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43568 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6612803 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6730163 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543624

Total number of triples: 16.